Rani Therapeutics Inc.
RANI | NASDAQ
$0.79
$0 (+0.08%)
Sep 22, 2026, 1:49 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.17M | 3.17M | 1.63M | 1.2M | 1.2M | 1.2M | 1.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.96M | 2.72M | 2.93M | 3.04M | 1.13M |
Cost of Revenue | 161K | 161K | n/a | n/a | n/a | n/a | 248K | 248K | 248K | 248K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 3.01M | 3.01M | 1.63M | 1.2M | 1.2M | 1.2M | 780K | -248K | -248K | -248K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.96M | 2.72M | 2.93M | 3.04M | 1.13M |
Operating Income | -32.96M | -34.64M | -38.31M | -44.73M | -49.28M | -51.29M | -53.32M | -51.79M | -57.85M | -63.62M | -66.1M | -70.15M | -68.63M | -66.19M | -63.45M | -59.33M | -70.77M | -60.18M | -51.6M | -43.18M | -18.23M | -16.36M |
Interest Income | 864K | 1.02M | 828K | 804K | 1.15M | 1.43M | 1.76M | 2.08M | 2.5M | 2.96M | 3.3M | 3.44M | 2.98M | 2.12M | 1.25M | 445K | 79K | 57K | 89K | 73K | 73K | 72K |
Pretax Income | -32.39M | -36.23M | -40.95M | -47.6M | -52.41M | -54.54M | -56.58M | -54.92M | -60.53M | -65.83M | -67.88M | -71.21M | -69.19M | -66.34M | -63.28M | -59.24M | -71.59M | -61.26M | -53.05M | -45.45M | -19.66M | -16.89M |
Net Income | -30.14M | -29.44M | -29.67M | -28.32M | -29.69M | -29.8M | -30.02M | -28.17M | -30.58M | -33.08M | -33.97M | -35.66M | -34.42M | -32.74M | -30.59M | -26.99M | -22.18M | -20.04M | -19.41M | -30.93M | -30.67M | -27.9M |
Selling & General & Admin | 19.53M | 19.01M | 19.74M | 20.11M | 21.7M | 23.11M | 23.7M | 24.06M | 25.07M | 25.87M | 26.48M | 27.74M | 28.35M | 27.46M | 26.84M | 25.69M | 34.28M | 31.42M | 27.83M | 23.71M | 8.73M | 6.16M |
Research & Development | 18.31M | 18.8M | 20.21M | 22.11M | 25.06M | 25.67M | 26.68M | 27.48M | 32.53M | 37.5M | 39.62M | 42.4M | 40.29M | 38.73M | 36.61M | 33.64M | 36.5M | 30.73M | 26.48M | 22.4M | 12.53M | 11.33M |
Other Expenses | -161K | -161K | n/a | 3.71M | 3.71M | 3.71M | 3.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 37.68M | 37.64M | 39.94M | 45.93M | 50.48M | 52.49M | 54.1M | 51.54M | 57.6M | 63.37M | 66.1M | 70.15M | 68.63M | 66.19M | 63.45M | 59.33M | 70.77M | 62.14M | 54.32M | 46.11M | 21.26M | 17.49M |
Interest Expense | 1.15M | 2.04M | 2.89M | 3.67M | 4.28M | 4.68M | 5.03M | 5.2M | 5.18M | 5.17M | 5.09M | 4.51M | 3.54M | 2.28M | 1.07M | 352K | 110K | 279K | 467K | 549K | 503K | 336K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -248K | -248K | -248K | -248K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 27.3M | 37.81M | 39.94M | 45.93M | 50.48M | 52.49M | 54.34M | 51.79M | 57.85M | 63.62M | 66.1M | 70.15M | 68.63M | 66.19M | 63.45M | 59.33M | 70.77M | 62.14M | 54.32M | 46.11M | 21.26M | 17.49M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -41K | -148K | 6K | 69K | 70K | 214K | 61K | 41K | 93K | 61K | 66K |
Shares Outstanding (Basic) | 187.17M | 180M | 147.09M | 36.54M | 36.54M | 33.44M | 32.66M | 28.84M | 26.32M | 26.03M | 25.87M | 25.55M | 25.35M | 25.24M | 24.91M | 24.47M | 24.37M | 21.41M | 19.44M | 19.44M | 18.81M | 18.74M |
Shares Outstanding (Diluted) | 187.17M | 180M | 147.09M | 36.54M | 36.54M | 33.44M | 32.66M | 28.84M | 26.32M | 26.03M | 25.87M | 25.55M | 25.35M | 25.24M | 24.91M | 24.47M | 24.37M | 21.41M | 19.44M | 19.44M | 18.81M | 18.74M |
EPS (Basic) | -0.27 | -0.41 | -0.59 | -0.79 | -0.91 | -0.99 | -1.06 | -1.06 | -1.18 | -1.29 | -1.33 | -1.41 | -1.38 | -1.32 | -1.28 | -1.19 | -1.02 | -1 | -1.01 | -1.64 | -1.63 | -1.48 |
EPS (Diluted) | -0.27 | -0.41 | -0.59 | -0.79 | -0.91 | -0.99 | -1.06 | -1.06 | -1.18 | -1.29 | -1.33 | -1.41 | -1.38 | -1.32 | -1.28 | -1.19 | -1.02 | -1 | -1.01 | -1.64 | -1.63 | -1.48 |
EBITDA | -32.1M | -33.38M | -37.16M | -42.95M | -47.11M | -48.83M | -50.53M | -48.73M | -54.4M | -59.78M | -61.98M | -65.93M | -64.96M | -63.44M | -61.66M | -58.4M | -71.01M | -60.51M | -52.08M | -44.4M | -18.63M | -16M |
EBIT | -23.84M | -34.19M | -38.06M | -43.93M | -48.13M | -49.86M | -51.55M | -49.71M | -55.35M | -60.66M | -62.8M | -66.7M | -65.65M | -64.06M | -62.2M | -58.89M | -71.48M | -60.98M | -52.58M | -44.92M | -19.18M | -16.57M |
Depreciation & Amortization | 570K | 810K | 900K | 980K | 1.02M | 1.03M | 1.03M | 989K | 948K | 882K | 822K | 769K | 692K | 625K | 548K | 487K | 466K | 472K | 497K | 526K | 550K | 572K |
Add to Watchlist
Select watchlists to add or remove RANI